7,487 Shares in Omega Healthcare Investors, Inc. $OHI Purchased by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC bought a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 7,487 shares of the real estate investment trust’s stock, valued at approximately $274,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $26,000. Bayforest Capital Ltd grew its stake in shares of Omega Healthcare Investors by 395.2% during the 2nd quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock worth $41,000 after purchasing an additional 901 shares during the period. Cullen Frost Bankers Inc. acquired a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $41,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of Omega Healthcare Investors by 562.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock worth $67,000 after purchasing an additional 1,552 shares during the period. Finally, Register Financial Advisors LLC acquired a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $73,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Up 1.0%

Shares of OHI opened at $39.91 on Friday. The firm has a market cap of $11.77 billion, a P/E ratio of 24.64, a PEG ratio of 1.85 and a beta of 0.70. The stock’s 50 day moving average is $41.47 and its two-hundred day moving average is $39.08. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.02. The business had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Monday, November 3rd will be issued a $0.67 dividend. The ex-dividend date is Monday, November 3rd. This represents a $2.68 dividend on an annualized basis and a yield of 6.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 165.43%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Cantor Fitzgerald assumed coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective on the stock. Wells Fargo & Company raised their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a report on Tuesday, October 21st. Scotiabank raised their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, August 28th. Royal Bank Of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a report on Thursday, August 7th. Finally, Truist Financial raised their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a report on Wednesday, September 3rd. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and an average price target of $43.86.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.